Navigation Links
BELLUS HEALTH reports results for first quarter of fiscal 2008
Date:5/5/2008

LAVAL, QC, May 5 /PRNewswire-FirstCall/ - BELLUS Health Inc. (NASDAQ: BLUS; TSX: BLU, formerly known as Neurochem Inc.) reported results for the first quarter ended March 31, 2008. The Company reported a net loss of $12,902,000 ($0.26 per share) for the quarter, compared to $21,016,000 ($0.54 per share) for the same period the previous year. The decrease in the net loss is mainly due to a reduction in research and development (R&D) expenses, before research tax credits and grants, which amounted to $8,780,000 this quarter, compared to $16,828,000 for the same period the previous year. The decrease in R&D expenses is mainly attributable to a reduction in expenses incurred in relation to the development of tramiprosate (ALZHEMED(TM); homotaurine) for the treatment of Alzheimer's disease, following the Company's decision in November 2007 to terminate the tramiprosate (ALZHEMED(TM)) pharmaceutical drug development program and to take steps to commercialize homotaurine (VIVIMIND(TM)) as a branded nutraceutical.

As at March 31, 2008, the Company had available cash, cash equivalents and marketable securities of $43,448,000, compared to $58,672,000 at December 31, 2007. BELLUS Health is expecting to further reduce its burn rate during fiscal 2008.

Consolidated Financial Results Highlights

The shareholders of Neurochem Inc. approved the change of its name to "BELLUS Health Inc." at the Annual and Special Shareholders' Meeting on April 15, 2008. The new stock ticker symbols, BLUS (NASDAQ) and BLU (TSX), came into use on April 21, 2008.

The Management's Discussion and Analysis (MD&A) provides a review of the Company's operations, performance and financial position for the quarter ended March 31, 2008, compared with the quarter ended March 31, 2007. It should be read in conjunction with the Company's unaudited consolidated financial statements for the three-month period ended March 31, 2008, as well as the Company's audited consolidated financ
'/>"/>

SOURCE BELLUS Health Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine news :

1. At Annual and Special Meeting of Shareholders - Neurochem to officially adopt new name - BELLUS Health - And to provide update on programs including first new natural health product, VIVIMIND(TM)
2. Penn study finds pro-death proteins required to regulate healthy immune function
3. UCLA researchers identify markers that may predict diabetes in still-healthy people
4. Air pollution linked to cardiovascular risk indices in healthy young adults
5. More proof needed of safety and quality of electronic personal health records
6. Health care incentive model offers collaborative approach
7. Loneliness is bad for your health
8. Mailman School of Public Health study examines link between racial discrimination and substance use
9. Green Tea May Brew Up Healthier Skin
10. For Health Info, Women Often Turn to the Web
11. Record Number of Americans Lack Health Insurance

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...ionary new cell phones that direct microwave signa...in early 2010 from Aerius International Ltd. , ... Revolutionary new cell phones that direct microwa...ailable in early 2010 from Aerius International Lt...n Technology Award in wireless communication from ...
(Date:12/2/2009)...ay, more than 900 runners and walkers from Las Veg...ne at the Rock ‘n’ Roll Las Vegas Half... million for the Crohn,s & Colitis Foundation ...hallenge (www.ccteamchallenge). As the official ch...ch, education, and support initiatives to benefit ...
(Date:12/2/2009)...wswire-USNewswire/ -- The American Health Informat...day announced Alan F. Dowling, PhD, will be the ne...ormation management (HIM) leader. Dr. Dowling,s e...ademia, systems management, strategic expertise, g...ve leadership. He is scheduled to take office Jan...
(Date:12/2/2009)... Pro-abortion activists... their campaign against the U.S. House bill,s pro-...ed for Life President and CEO Charmaine Yoest rele...bby,s effort to expand taxpayer funding of abortio...the feminist groups and the abortion lobby actuall...
(Date:12/2/2009)...shington Post Highlights Dangers ,, WASHING...atholic bishops have their way, many medical treat...d may be under threat. The pressure that the US b...lthcare reform has been widely reported. An ad in ...ly impact if that pressure to influence healthcare...
Breaking Medicine News(10 mins):Health News:New AERIUS Cell Phones Direct Microwave Signals Away from Users 2Health News:Raising Millions for Team Challenge through Rock ‘n' Roll Las Vegas Half Marathon Program Brings Hundreds From Across the Country to Raise Funds for Crohn's & Colitis 2Health News:Raising Millions for Team Challenge through Rock ‘n' Roll Las Vegas Half Marathon Program Brings Hundreds From Across the Country to Raise Funds for Crohn's & Colitis 3Health News:Raising Millions for Team Challenge through Rock ‘n' Roll Las Vegas Half Marathon Program Brings Hundreds From Across the Country to Raise Funds for Crohn's & Colitis 4Health News:Dr. Alan F. Dowling Named AHIMA's Next Chief Executive Officer 2Health News:Everybody's Healthcare Is Threatened by Catholic Bishops' Interference 2
...and Consultants Instant Access to Dental ...RISBURG, Pa., Feb. 5 National dental insurer Unit...release of its newest online,support tool, Concord...ups, view and export detailed commission payment,r...
...chers at Rush University Medical Center, published...Neuroradiology, finds that half of patients underg...nd well to clopidogrel. Clopidogrel (Plavix) and a...is) and reclosure of the artery (re-stenosis). , ...
...termined walking abilities of patients, study sugg...-- The same device that keeps you from getting los...s a way to determine the severity of peripheral ar... this study, the researchers used Global Positioni...
...arance on Training Magazine,s list ranks 33, COLU...,highly developed education and leadership program...rporations providing career development for,employ... was honored for its professional and personal dev...
...iled drug launch can cost,a pharmaceutical company...,up costing a company more. Leading pharmaceutical...n annual sales with a re-launch, according to a,st...eexamination of initial missteps with a new core,m...
..., refine and replace the use of animals in researc...he 3Rs was unveiled today at a symposium marking t...ting Committee on the Validation of Alternative Me...acceptance of alternative test methods. A corners...
Other Medicine News:Health News:United Concordia Unveils New Online Capabilities for Producers 2Health News:Half of patients undergoing cerebrovascular stent placement respond poorly to clopidogrel 2Health News:GPS Devices Measure Severity of Peripheral Artery Disease 2Health News:Training Magazine Applauds Aflac's Employee Learning Programs 2Health News:Training Magazine Applauds Aflac's Employee Learning Programs 3Health News:Redefining a Product's Identity Key to a Successful Re-Launch 2Health News:Plan expedites alternatives to animal testing 2Health News:Plan expedites alternatives to animal testing 3
(Date:12/2/2009)..., , WALTHAM, Mass., Dec. 2 /PRNewswire/ ...research and advisory firms for pharmaceutical and...several established branded atypical antipsychotic...ease from $6.3 billion in 2008 to $5.2 billion in ... Spain, the United Kingdom and Japan. ,, The ne...
(Date:12/2/2009)..., , INCLINE VILLAGE, Nev., Dec. 2 /PRNewswir... PDLI ) today announced that it has established t...00 million special dividend as $1.67 per share. Th...l holders of the Company,s stock as of the Decembe...ated the approximate per share amount of the divid...
(Date:12/2/2009)..., , NANJING, China, Dec. 2 /PRNewsw...e" or the "Company") (NYSE: SCR ), a leading pha...t, manufacturing, and marketing of branded,generic...eported that its,subsidiary Jiangsu Yanshen Biolog...) has suspended production of all its products in ...
Breaking Medicine Technology:Generic Erosion of Established Branded Atypical Antipsychotics Will Cause the Schizophrenia Drug Market To Decline More Than $1 Billion by 2013 2PDL BioPharma Announces December 15 Special Dividend Payment of $1.67 per Share 2PDL BioPharma Announces December 15 Special Dividend Payment of $1.67 per Share 3Simcere Pharmaceutical Group Announces Jiangsu Yanshen's Voluntary Suspension of Production 2Simcere Pharmaceutical Group Announces Jiangsu Yanshen's Voluntary Suspension of Production 3This Fathers Day Give Dad a Gift Straight for the Heart 49181 1This Fathers Day Give Dad a Gift Straight for the Heart 49181 2This Fathers Day Give Dad a Gift Straight for the Heart 49181 3Bhelliom Taps Into a Miracle Billion Dollar Berry Blend With Their All New Mr Energy 8 Hour Energy Shot 49177 1Bhelliom Taps Into a Miracle Billion Dollar Berry Blend With Their All New Mr Energy 8 Hour Energy Shot 49177 2Bhelliom Taps Into a Miracle Billion Dollar Berry Blend With Their All New Mr Energy 8 Hour Energy Shot 49177 3Michigan State Medical Society Collaborates With Microsoft to Expand Health Care Technology in Michigan 49172 1Michigan State Medical Society Collaborates With Microsoft to Expand Health Care Technology in Michigan 49172 2Michigan State Medical Society Collaborates With Microsoft to Expand Health Care Technology in Michigan 49172 3
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
Medicine Products: